前列腺癌免疫疗法：稳步前行，切勿急进。 - Suppr

Suppr

超能文献

Immunotherapy for prostate cancer: walk, don't run.

作者信息

Drake Charles G

出版信息

J Clin Oncol. 2009 Sep 1;27(25):4035-7. doi: 10.1200/JCO.2009.22.2299. Epub 2009 Jul 27.

DOI:10.1200/JCO.2009.22.2299

PMID:19635998

Abstract

摘要

相似文献

Immunotherapy for prostate cancer: walk, don't run.前列腺癌免疫疗法：稳步前行，切勿急进。

J Clin Oncol. 2009 Sep 1;27(25):4035-7. doi: 10.1200/JCO.2009.22.2299. Epub 2009 Jul 27.

A phase I study of a DNA vaccine targeting prostatic Acid phosphatase in patients with stage D0 prostate cancer.一项针对D0期前列腺癌患者的靶向前列腺酸性磷酸酶DNA疫苗的I期研究。

Clin Genitourin Cancer. 2005 Dec;4(3):215-8. doi: 10.3816/CGC.2005.n.036.

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.编码前列腺酸性磷酸酶的DNA疫苗在D0期前列腺癌患者中的安全性和免疫疗效。

J Clin Oncol. 2009 Sep 1;27(25):4047-54. doi: 10.1200/JCO.2008.19.9968. Epub 2009 Jul 27.

Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer.Sipuleucel-T 的研发：用于治疗转移性去势抵抗性前列腺癌的自体细胞免疫疗法。

Vaccine. 2012 Jun 19;30(29):4394-7. doi: 10.1016/j.vaccine.2011.11.058. Epub 2011 Nov 26.

New therapies for castration-resistant prostate cancer.去势抵抗性前列腺癌的新疗法。

N Engl J Med. 2010 Jul 29;363(5):479-81. doi: 10.1056/NEJMe1006300.

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.在接受确定性局部治疗后出现血清学进展的前列腺癌患者中，采用前列腺酸性磷酸酶脉冲抗原呈递细胞联合免疫疗法（普列威）加贝伐单抗进行治疗。

Cancer. 2006 Jul 1;107(1):67-74. doi: 10.1002/cncr.21956.

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.用负载抗原的树突状细胞对激素难治性前列腺癌进行免疫治疗。

J Clin Oncol. 2000 Dec 1;18(23):3894-903. doi: 10.1200/JCO.2000.18.23.3894.

Emerging concepts in GM-CSF gene-transduced tumor vaccines for human prostate cancer.用于人类前列腺癌的粒细胞-巨噬细胞集落刺激因子基因转导肿瘤疫苗的新观念

Curr Opin Mol Ther. 1999 Feb;1(1):64-71.

Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.采用分泌粒细胞巨噬细胞集落刺激因子的异基因细胞免疫疗法治疗前列腺癌生化复发

J Urol. 2008 Nov;180(5):2011-7; discussion 2017-8. doi: 10.1016/j.juro.2008.07.048. Epub 2008 Sep 17.

Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.新型人端粒酶逆转录酶（hTERT）肽疫苗用于转移性激素初治前列腺癌男性患者的I/IIa期临床试验

Cancer Immunol Immunother. 2017 Jul;66(7):891-901. doi: 10.1007/s00262-017-1994-y. Epub 2017 Apr 8.

引用本文的文献

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches.克服去势抵抗性前列腺癌中的耐药性：当前机制与新兴治疗方法

Cancer Drug Resist. 2025 Feb 19;8:9. doi: 10.20517/cdr.2024.173. eCollection 2025.

Emerging Cancer Immunotherapies: Cutting-Edge Advances and Innovations in Development.新兴癌症免疫疗法：开发中的前沿进展与创新。

Med Sci (Basel). 2024 Aug 28;12(3):43. doi: 10.3390/medsci12030043.

Cancer vaccines in the clinic.临床中的癌症疫苗

Bioeng Transl Med. 2023 Oct 27;9(1):e10588. doi: 10.1002/btm2.10588. eCollection 2024 Jan.

Vaccines as treatments for prostate cancer.疫苗作为前列腺癌的治疗方法。

Nat Rev Urol. 2023 Sep;20(9):544-559. doi: 10.1038/s41585-023-00739-w. Epub 2023 Mar 6.

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.混合 20 肽癌症疫苗联合多西他赛和地塞米松治疗去势抵抗性前列腺癌：一项随机 II 期试验。

Cancer Immunol Immunother. 2020 May;69(5):847-857. doi: 10.1007/s00262-020-02498-8. Epub 2020 Feb 5.

Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.前列腺癌免疫疗法，尤其是与雄激素剥夺疗法或放射治疗联合使用时。采用定制的药物基因组学方法来克服免疫疗法对癌症的耐药性。

G Chir. 2017 Sep-Oct;37(5):225-235. doi: 10.11138/gchir/2016.37.5.225.

A Perspective of Immunotherapy for Prostate Cancer.前列腺癌免疫治疗的展望

Cancers (Basel). 2016 Jul 7;8(7):64. doi: 10.3390/cancers8070064.

Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.基于纳米颗粒的抗原呈递细胞调控用于癌症免疫治疗

Small. 2015 Nov 4;11(41):5483-96. doi: 10.1002/smll.201501284. Epub 2015 Sep 2.

Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer.超越免疫抑制：前列腺癌中的免疫疗法。

Biomed Res Int. 2015;2015:794968. doi: 10.1155/2015/794968. Epub 2015 Jun 16.

Immunotherapy in prostate cancer: review of the current evidence.前列腺癌的免疫疗法：当前证据综述

Clin Transl Oncol. 2015 May;17(5):339-57. doi: 10.1007/s12094-014-1259-6. Epub 2014 Dec 6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验